Spinal Lamina Ii Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Spinal Lamina II neurons, also known as the Substantia Gelatinosa, constitute a critical processing center within the dorsal horn of the spinal cord. These neurons play a fundamental role in modulating nociceptive (pain) transmission, sensory gating, and are increasingly recognized for their involvement in neurodegenerative disease processes affecting the central nervous system.
¶ Location and Structure
Lamina II is situated in the superficial dorsal horn of the spinal cord, immediately dorsal to Lamina III. The region is characterized by a dense network of interneurons and glial cells, with a distinctive gelatinous appearance due to its high density of neuropil and relatively low cell body density. The substantia gelatinosa extends throughout the rostrocaudal axis of the spinal cord, with the highest concentration in cervical and lumbar enlargements corresponding to upper and lower limb innervation.
The Lamina II neuronal population consists primarily of:
- GABAergic interneurons (approximately 30-40%): Use gamma-aminobutyric acid (GABA) as the primary inhibitory neurotransmitter
- Glutamatergic interneurons (approximately 50-60%): Use glutamate for excitatory transmission
- Glycinergic neurons: Co-localize with GABA in some populations
- Peptidergic neurons: Express neuropeptides such as substance P, calcitonin gene-related peptide (CGRP), and somatostatin
| Marker |
Expression |
Significance |
| GAD67 |
High |
GABA synthesis enzyme |
| VGLUT2 |
High |
Vesicular glutamate transporter |
| PKCγ |
Subset |
Protein kinase C gamma isoform |
| Calretinin |
Subset |
Calcium binding protein |
| NPY |
Subset |
Neuropeptide Y |
Lamina II serves as the primary gateway for processing nociceptive (pain) information from peripheral nociceptors. The region receives input from Aδ and C fiber primary afferents that carry information about potentially tissue-damaging stimuli. Within Lamina II, these inputs undergo significant processing through complex synaptic interactions between excitatory and inhibitory interneurons.
The neuronal circuits within Lamina II perform several critical functions:
- Signal Integration: Convergence of multiple sensory inputs allows for spatial and temporal integration of pain signals
- Modulation: Inhibitory interneurons provide presynaptic and postsynaptic inhibition to modulate pain transmission
- Gate Control: The balance between excitatory and inhibitory signaling determines whether pain signals propagate to supraspinal centers
- Plasticity: Activity-dependent changes in synaptic strength allow for sensitization and habituation phenomena
The substantia gelatinosa implements a "gate control" mechanism whereby:
- Low-intensity, non-noxious input (Aβ fibers) can activate inhibitory interneurons
- This inhibition suppresses the transmission of higher-intensity nociceptive signals
- The net effect is selective filtering of sensory information
Emerging evidence indicates Lamina II neurons also participate in itch sensation. Specific populations of interneurons expressing gastrin-releasing peptide (GRP) and its receptor (GRPR) are implicated in itch signaling, demonstrating the complex multiplexing of sensory modalities within this region.
While Lamina II is not traditionally considered a primary focus of Alzheimer's disease (AD) pathology, emerging research suggests several connections:
- Cholinergic modulation: Loss of basal forebrain cholinergic neurons in AD may disrupt the cholinergic modulation of dorsal horn pain circuits, potentially contributing to altered pain perception in AD patients
- Neuroinflammation: Systemic inflammation in AD may affect Lamina II neuronal function
- Pain perception changes: Clinical observations indicate altered pain thresholds and increased pain sensitivity in AD patients, possibly involving dysregulated sensory processing
Lamina II involvement in Parkinson's disease (PD) relates to:
- Alpha-synuclein pathology: While primarily affecting subcortical structures, PD pathology may extend to spinal cord regions
- Pain comorbidities: Up to 50-80% of PD patients experience pain, often with neuropathic characteristics
- Dopaminergic modulation: Dopaminergic projections from the ventrolateral periaqueductal gray modulate dorsal horn pain circuits, and these may be affected in PD
Lamina II may be affected in ALS through:
- Motor neuron degeneration: While primarily affecting upper and lower motor neurons, ALS may involve propriospinal neurons that interconnect with Lamina II
- Sensory involvement: Some ALS patients experience sensory symptoms, potentially involving dorsal horn circuits
A key intersection between neurodegenerative diseases and Lamina II function is the development of chronic pain:
- Central sensitization: Prolonged nociceptive input can lead to maladaptive plasticity in Lamina II, resulting in chronic pain states
- Loss of inhibition: Neurodegenerative processes may selectively affect inhibitory interneurons, reducing pain gating capacity
- Glial activation: Activated microglia and astrocytes in the dorsal horn contribute to pain hypersensitization
Several drug classes target Lamina II circuitry:
| Drug Class |
Mechanism |
Application |
| Gabapentinoids (gabapentin, pregabalin) |
Bind to α2δ subunit of voltage-gated calcium channels |
Neuropathic pain |
| Opioids |
Activate μ-opioid receptors on interneurons |
Severe pain |
| Baclofen |
GABA-B receptor agonist |
Spasticity, pain |
| SSRI/SNRIs |
Enhance descending inhibition |
Chronic pain |
- Spinal cord stimulation: Activates dorsal horn circuits including Lamina II
- Dorsal root ganglion stimulation: Modulates primary afferent input
- Transcranial magnetic stimulation: May affect descending pain modulatory systems
- Gene therapy: Targeted delivery of analgesic peptides
- Cell therapy: Transplantation of GABAergic interneuron progenitors
- Optogenetics: Precise control of specific neuronal populations
- Rodent models: Extensive characterization of rodent Lamina II circuitry
- Transgenic models: Mice lacking specific interneuron populations
- ** lesion models**: Selective ablation of inhibitory neurons
- Organotypic slice cultures: Maintain dorsal horn circuitry
- iPSC-derived neurons: Patient-specific models
- Microfluidic devices: Compartmentalized neuron cultures
Spinal Lamina Ii Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Spinal Lamina Ii Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Yoshimura M, Furue H. Mechanisms of pain processing in the spinal dorsal horn. J Physiol. 2006;577(Pt 3):615-618
- Todd AJ. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci. 2010;11(12):823-836
- Kuner R. Central mechanisms of pathological pain. Nat Med. 2010;16(11):1258-1266
- Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895-926
- Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267-284
- Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288(5472):1765-1768